Timothy Herpin

individual

Ecosystem influencer

About

Timothy Herpin is a biotech business development executive and current Chief Business Officer of AM-Pharma. His background spans senior partnering and transactions roles at Santa Ana Bio, Johnson & Johnson, Caribou Biosciences, AstraZeneca, and Bristol-Myers Squibb, with earlier work as a medicinal chemist. His profile is centered on licensing, strategic partnerships, and dealmaking across biotech and pharma rather than fund management or personal investing.

Areas of interest

biotechpharmaceuticalsbusiness developmentlicensingstrategic partnershipsoncologyneuroscienceinfectious diseasevaccinesCRISPRgene editingimmunologyautoimmune diseaseinflammatory disease